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it ’s all about principle : how
patent trolling , over broad
patents , evergreening , and
patent shelving represent a
departure from the patent
clause and how to return to the
principle of the patent clause

Morgan L. Stringer*

Abstract This article explores differing patent abuses
that reflect how current patent law has swung drastically away
from the Patent Clause of the U.S. Constitution. The purpose of
the Patent Clause is to ensure that inventors are given a limited
monopoly in order to encourage innovation, or to “progress the
useful arts and sciences.” There are many forms of patent abuse,
but this article will explore patent trolls, overbroad patents,
evergreening, and patent shelving as forms of patent abuse that
reflect a departure from the Constitutional principle of progress
in patent law. Each of these patent abuses hinders progress, so
according to the Patent Clause, Congress has the power to correct
these abuses and must return to this Constitutional principle
of progress. In addition, the Court must answer inconsistent
or unanswered questions, where Congress has failed to do so.
All of these patent abuses are related to one another, so solving
one of these patent abuses will help prevent another patent
abuse discussed. Furthermore, this article also proposes various
solutions to decrease and prevent patent trolling, overbroad
patents, evergreening, and patent shelving.
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I. I ntroduction
Patent law goes as far back in the United States as the very founding. The
Constitution states that Congress has the power, “to promote the Progress
of Science and useful Arts, by securing for limited Times to Authors and
Inventors the exclusive Right to their respective Writings and Discoveries.”1
Allowing authors and inventors to maintain an exclusive right enables them
to reap the rewards of a monopoly in exchange for revealing the “manner
of making and using the invention” for the public good. 2 In addition, the
Patent Clause states that “upon the expiration of the patent the public be
left free to use the invention.”3 The purpose of patent law is clear. In order
to promote science and the useful arts, Congress has the power to grant a
limited exclusive monopoly to the author or inventor, in exchange for the
public being able to later benefit. However, several abuses of the patent system have emerged. A doctrine intended to improve society through scientific
and artistic advancement has now warped to become a way for corporations
and individuals to maximize profit and maintain monopolies in a way that
is antithetical to progress.
Four major ways for patent holders to abuse patents have emerged that
this article will discuss: patent trolling, overbroad patents, evergreening, and
patent shelving. It is vital to discuss these four patent abuses in conjunction
with one another because together these abuses represent a shift in patent
law away from the U.S. Patent Clause. In addition, curbing each of these
abuses individually has an impact on another patent abuse that is discussed.
Part I of this article will discuss the origins of patent law and examples of
how it has changed and developed. In addition, this part will also document
the history of the various types of patent abuse discussed in this article. Part
II of this article will discuss four types of patent abuses: (1) patent trolling,
(2) overbroad patents, (3) evergreening, and (4) patent shelving. Part II will
also discuss why and how these patent abuses must be corrected and how
these abuses relate to one another. Often one of these patent abuses ending
will help curb patent abuse present in another area. Additionally, these four
patent abuses discussed in conjunction reveal the larger issue of patent law
straying from the Patent Clause of the Constitution.

1
2

3

U.S.C.A. Const. Art. I § 8, cl. 8.
Scott Paper Co. v. Marcalus Mfg. Co., 1945 SCC OnLine US SC 152 : 90 L Ed 47 : 326 US
249, 252 (1945 (citing Special Equipment Co. v. Coe, 1945 SCC OnLine US SC 62 : 89 L
Ed 1006 : 324 US 370, 377 (1945)).
Id.
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II. Background
A. History of Patent Law and its Purpose
In 1624, English Parliament passed the Statute of Monopolies, which allowed
inventors to have limited monopolies of 14 years, limiting the Crown’s ability to grant more extensive monopolies.4 The statute only allowed for a
monopoly over “manners of new manufacture.”5 These monopolies were
not granted if the invention was “mischievous to the state,” or “generally
inconvenient.”6 One example of “mischievous to the state” would be if it
raised the prices of commodities.7 The founders used the spirit of the English
law in their own adaptation of patent law, which is reflected in the Patent
Clause of the U.S. Constitution. The Patent Clause does not restrict patents
based on mischievousness, nor does it limit patents to manners of new manufacture, like the English law, but it does include that a limited monopoly
should be enjoyed by inventors, to encourage people to invent and once the
limited monopoly ends, then that creation may be enjoyed by the public,
who can then innovate and improve upon that invention. The ideas of progress and scientific achievement were very important to the founders, as they
were influenced by the ideals of the Enlightenment. In fact, the founding
fathers opposed perpetual monopolies. Thomas Jefferson stated that a complete monopoly would “embarrass society with monopolies for every utensil
existing, and in all details of life.”8
Passed in 1790, the US Patent Act granted a 14-year monopoly to “useful, important, and new” inventions.9 This statute also set up a commission
which would grant patents. This commission consisted of the Secretary of
State, the Secretary of War, and the Attorney General. At least two of the
commission members had to find an invention to be “sufficiently useful and
important,” in order for a patent to be granted. However, this process was
slow, as the members of the commission were not able to meet together as
often as desired. In 1793, Thomas Jefferson, then Secretary of State, amended
the Patent Act to grant patents for “any new and useful art, machine, manufacture, or composition of matter, and any new and useful improvement on

4

5
6
7
8
9

Ladas & Perry, Education Center, “A Brief History of the Patent Law of the United States.”
http://ladas.com/a-brief-history-of-the-patent-law-of-the-united-states-2/.
Ladas & Perry, supra note 4.
Ladas & Perry, supra note 4.
Ladas & Perry, supra note 4.
Ladas & Perry, supra note 4.
Pamela Collins, “A Brief History of U.S. Patent Law,” Head, Johnson, & Kachigan, P.C. May
18, 2012. http://www.hjklaw.com/blogs/archive/entry/a_brief_history_of_us_patent_law.
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any art, machine, manufacture, or composition of matter.”10 The law also
provided that the inventor should give a petition for patent to the Secretary
of State. This effectively eliminated a commission for patent approval.11
The Patent Act of 1836 created a Patent Office within the Department
of State, and created the office of Patent Commissioner, who would be
appointed by the president. The statute also contained a provision for patent
extensions. The extension would be for an additional seven years added on
to the initial 14-year patent term, so it was possible to obtain a patent for
21 years. A patentee had to apply to the Commissioner of the Patent Office
for an extension, then a hearing would take place before the Secretary of
State, Patent Commissioner, and Solicitor of the Treasury. At the hearing,
this committee would hear evidence for and against the patent extension.
The Patent Act of 1836 provided that an extension could be granted if “without neglect or fault on his part, having failed to obtain, from the use and
sale of his invention, a reasonable remuneration for the time, ingenuity, and
expense bestowed upon the same.”12 In 1861, the extension was eliminated
entirely and a term of 17 years was put into place.13
The Patent Act of 1952 continued the Patent Office, although previously,
the Patent Office was moved to the Department of Commerce. The Patent
Act of 1952 added an additional requirement to patentability: non-obviousness.14 Furthermore, patentees had to provide a specification, which included
a written description of the patent, and drawings and models or specimens,
if needed.15 The patent term was also later changed to 20 years, which is
the current patent term.16 In 2011, the Leahy-Smith America Invents Act
changed the patent system to where the patent is given to the first to file the
patent, rather than the first to invent.17 This applies to any patents filed after
March 16, 2013, but all other patents fall under the prior system of first to
invent.18

10
11
12
13
14
15
16
17
18

Ladas & Perry, supra note 4.
1 Stat. 318, 2 Cong. Ch. 11, 1 Stat. 318, 2 Cong. Ch. 11.
Id. at Sec. 18.
12 Stat. 246, 249, 16.
82 P.L. 593, 66 Stat. 792, 82 Cong. Ch. 950, Sec. 103.
Id., at Sec. 112, 113, 114.
Id.
112 P.L. 29, 125 Stat. 284, Sec. 3.
Id.
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B. Origins of Patent Law Abuse
i. Patent Trolls
Patent trolls are said to be as old as patent law in the United States itself.
Some claim that Eli Whitney was a patent troll because when Whitney’s first
attempts to manufacture and sell the cotton gin failed, Whitney turned to
suing the plantation owners who used Whitney’s cotton gin to make money
from his invention.19 In 1879, patent attorney George Selden claimed a patent for the automobile, but he did not “choose to issue the patent” until
1895. After the issuance of the automobile patent, Selden sued almost every
automobile manufacturer, and he was able to obtain licenses and money
from those licenses. 20 However, when Selden sued Henry Ford his success
came to an end. Ford fought Selden’s suit, and he won on appeal, where the
court determined that neither Ford nor any other automobile manufacturer
owed Selden anything.21
Patent trolls increased drastically after the 1970s and 80s. Jerome
Lemelson, an independent inventor, was able to enforce his patents against
other various entities, especially his patent on the barcode reader. 22 However
in a case that came to court involving this manner, the plaintiff in that case
was not Lemelson, himself, but rather Symbol and Cognex, 23 who manufactured and sold bar code scanners and related products. In 1998, their
customers received letters from Lemelson alleging that they were infringing
on Lemelson’s patents. 24 The plaintiffs would have to indemnify these customers if it was found that the customers had infringed on these patents.25
so Symbol and Cognex sued on the customers’ behalf. This case hinged on
whether the prosecution of laches was available to bar Lemelson’s claim
of infringement. 26 Here, the Court held it was an available defense and the
case was remanded. 27 However, in his total claims, Lemelson was awarded
19

20
21
22

23
24

25
26
27

Ryan Hauer, Another Attempt at Patent Reform: S.1013 The Patent Abuse Reduction Act
of 2013, 24 DePaul J. Art Tech. & Intell. Prop. L. 367, 370.
Hauer, supra, note 19, at 370-71.
Hauer, supra note 19, at 371.
Robin M. Davis, Failed Attempts to Dwarf the Patent Trolls: Permanent Injunctions in
Patent Infringement Cases Under the Proposed Patent Reform Act of 2005 and eBay
v. Mercexhange, 17 Cornell J.L & Pub. Pol’y 431, 432. (Generally citing Symbol
Technologies Inc. v. Lemelson Medical, Education & Research Foundation LP, 277 F 3d
1361 (Fed Cir 2002)).
The trial court consolidated the separate cases of each plaintiff into one.
Symbol Technologies Inc. v. Lemelson Medical, Education & Research Foundation LP,
277 F 3d 1361, 1363 (Fed Cir 2002).
Id.
Id.
Id., at 1363-68.
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over $1.5 billion in licensing fees. 28 This reward encouraged patent trolls to
send demand letters for patents. The term patent troll was first used when
Peter Detkin, Intel’s Assistant General Counsel used the term “patent troll”
to describe a “litigious-minded IP-holding company.”29 Detkin stated that a
patent troll was “somebody who tries to make a lot of money off of a patent
that they are not practicing and in most cases never practiced.”30
In modern times, patent trolls often own large shell companies.31 The
largest patent trolls can own thousands of shell companies, which hold thousands of patents.32 It can be difficult in litigation to reveal the identities of
these shell companies, or even to obtain damages from them because courts
are “hesitant to pierce the corporate veil.”33

ii. Overbroad Patents
The broader the claim, the more protection the inventor has under the law.
However, inventors realized they could further their monopolies by drafting
overbroad patents, or claims that go beyond what the inventor has actually
invented.
In 1922, Christian Nelson obtained a patent for the Eskimo Pie, an ice
cream bar. The patent’s claims described, “a core consisting of a block or
brick of ice cream, of general rectangular configuration, that is sealed within
a shell of edible material which may be like that employed in coating chocolate candies although preferably modified to harden at a lower temperature.”34 This patent shows that Nelson received a monopoly on chocolate
covered ice cream. In fact, an internal report of Eskimo Pie’s office states
that they celebrated the broadness of the patent because they not only patented their invention, but every single variation of their invention as well.35
Eskimo Pies then used its patent to sue competitors, but the patent was later
invalidated for its broadness.36
28

29

30
31
32
33
34

35
36

Davis, supra note 22. (Citing Teresa Riordan, “The Lemelson Foundation, named for a
Prolific Inventor, aims to Reward Inventions that Help Poor Countries Develop,” N.Y.
Times, Apr. 26, 2004 at C4).
Davis, supra note 22. (Citing Raymond P. Niro & Paul K. Vickrey, The Patent Troll Myth,
7 Sedona Conf. J. 153, 153 (2006)).
Hauer, supra note 19, at 369.
Hauer, supra note 19, at 371.
Hauer supra note 19, at 371.
Hauer, supra note 19, at 371-72.
Charles Duan, “Ice Cream Patent Headache,” Slate, Oct. 20, 2015, http://www.slate.
com/articles/technology/future_tense/2015/10/what_the_history_of_eskimo_pies_says_
about_software_patents_today.html.
Duan, supra note 34.
Duan, supra note 34, (citing Eskimo Pie Corpn. v. Levous, 24 F 2d 599, 600 (DNJ 1928).
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In modern times, overbroad patents are increasingly seen in the technology sector. This is due to changing terminology, which can be imprecise, and
the tendency of the claims to describe a function, which leads to general construction of claims.37 Overbroad patents, once granted, can be used against
competitors, who actually have invented what is claimed in the initial patent, unlike the initial patent holder.

iii. Evergreening
The origins of evergreening and even overbroad patent claims can be seen
in the first surge of patent litigation that occurred between the mid-1840s
to the mid-1880s. This litigation widely fell under the Patent Act of 1836.38
Since 1793, the patent law operated more as a “registration regime,” wherein
inventors would register patents, and the issue of the patent novelty or validity was left for the courts to decide. This led to widespread calls for change,
and Congress responded with the Patent Act of 1836. This act created a staff
of professional patent examiners within the Patent Office. Much of the litigation that arose in the mid-1840s resulted from inventions that fell under
previous law or patents that were granted “term extensions.”
Term extensions could be granted “legislatively, by Congressional private act, or administratively, under the 1836 Patent Act, by a board of senior federal officeholders consisting of the Secretary of State, the Solicitor of
the Treasury, and the Commissioner of Patents.”39 Beginning in 1848, the
Commissioner of Patents alone had the power to grant extensions.40 The
Commissioner of Patents granted extensions to certain patentees who had
“without neglect or fault on his part…failed to obtain, from the use and
sale of his invention, a reasonable remuneration for the time, ingenuity, and
expense bestowed upon the same.”41 These term extensions were “elastic”
and lobbying efforts helped inventors gain extensions for the most innovative patents of the day.42
One example of such a patent that was given a term extension and heavily litigated was Thomas Blanchard’s turning lathe, which enabled the
user to make irregular wood forms, like gun-stocks, in ten minutes, which

37

38
39
40
41
42

David J. Kappos, Investing in America’s Future Through Innovation: How the Debate
Over the Smart Phone Wars (Re)Raises Issues at the Foundation of Long-Term Incentive
Systems, 16 Stan. Tech. L. Rev. 485, 495.
Christopher Beauchamp, The First Patent Litigation Explosion, 125 Yale L.J. 848, 858.
Beauchamp, supra note 38, at 860 (citing § 18 5 Stat. at 124.)
Beauchamp, supra note 38, f. n. 36.
Beauchamp, supra note 38, 860 (citing § 18, 5 Stat. at 125).
Beauchamp, supra note 38.

34

The Indian Journal of Law and Technology

Vol. 13

required less manual labor.43 His patent was granted in 1819, but was not
widely enforced, so in 1834, Blanchard received a private act from Congress
which extended his patent another 14 years.44 Blanchard, with the extension in his hand, then used his extended monopoly to sue dozens of other
woodworkers.45
Charles Goodyear also used patent extensions and litigation. After he patented his rubber vulcanization method in 1844,46 Goodyear granted licenses
to rubber goods manufacturers. Goodyear also gained a “reissue amendment
to the patent that broadened its scope.”47 Goodyear then sued both licensed
and unlicensed manufacturers, bringing over 200 suits between the 1840s
and 1850s.48 After winning the “Great India-Rubber Case,” Goodyear was
granted a patent extension for another seven years because “no inventor
probably had ever been so harassed, so trampled upon, so plundered by that
sordid and licentious infringers known as ‘pirates.’”49
Some of the most contentious litigation in the 1850s was caused by the
“Sewing Machine Wars,” because it was very difficult to manufacture a
quality sewing machine without infringing on one of the many patents contained within a sewing machine.50 Eventually the leading manufacturers created a “patent pool” called the “Sewing Machine Combination.”51 Lawsuits
between the members of this pool decreased drastically; however, the suits
against non-members remained in place.52 Elias Howe, who held many of
the initial patents, also was able to extend his patents for another seven
years, in which he earned $2 million by the time his patent finally expired. 53
While these term extensions and patent reissues do not occur so explicitly
in modern law, one can see how these reissues and extensions were used
to perpetuate monopolies, rather than strike a balance between inventor
rights and innovation. In fact, I argue that these term extensions became the
precursor of evergreening. Additionally, the sewing machine debacle is an
example of how overbroad patents can limit innovation. In modern times,
evergreening is seen more in the pharmaceutical industry.
43
44
45
46
47
48
49

50
51
52
53

Beauchamp, supra note 38.
Beauchamp, supra, note 38, at, 860-61.
Beauchamp, supra, note 38, at 861.
Beauchamp, supra, note 38, at 864.
Beauchamp, supra note 38, at 865.
Beauchamp, supra, note 38, at 865.
Beauchamp, supra, note 38, at 865 (citing Charles Goodyear, 101 N. Am. Rev. 65, 98
(1865) (citing in re Goodyear Patent, 1858 Dec. Comm’r Pat. 9).
Beauchamp, supra, note 38, at 865.
Beauchamp, supra, note 38,at 865-66.
Beauchamp, supra, note 38, at 866.
Beauchamp, supra, note 38, at 866.
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iv. Patent Shelving
There are times when patents are not utilized or commercialized when a
patent is simply not profitable, but at other times patentees will purposefully “shelf” a patent for strategic reasons. 54 One example of this was when
Russian caviar manufacturer the Romanoff Caviar Company created artificial caviar, but it never marketed the artificial caviar because it did not want
to compete with its real caviar in the U.S. market.55 In the United States,
Xerox obtained a series of patents in order to preserve its market in “plain
paper photocopier technology,” but then Xerox never used or licensed those
patents. In a lawsuit over this issue, the court ruled there was no antitrust
violation because this was a lawful use of Xerox’s patent rights.56
In an even more egregious example of patent shelving, Liggett & Myers
Company believed they discovered a way to remove many of the harmful
carcinogens in cigarettes.57 However, the patent was never marketed and
research halted. This was because revealing that a safer cigarette was discovered would also admit that cigarettes were dangerous. 58 Phillip Morris
threatened to sue Liggett if Liggett “violated the industry agreement not to
disclose negative information on smoking and health.”59
Patent shelving also occurs in the pharmaceutical industry. A scientist
developed a “protein-binding factor,” which allowed EPO (erythropoietin)
to remain in the body, rather than being excreted, which increased the EPO
uptake by a ten- to fifty-fold factor. EPO assists in the creation of “oxygen-carrying” red blood cells and is effective in treating anemic people,
including pre-mature infants. The pharmaceutical company, Amgen, held
many of the patents related to EPO technology. Since this medication was
so effective, people would need less EPO, so Amgen was not interested in
marketing the product due to concerns about profits. However, since Amgen
held so many other vital components to EPO technology, no other pharmaceutical company could use the technology either.60 Therefore, a lifesaving
technology benefitted no one in the public, yet the patent law protected a
corporation in maintaining profits, while ensuring no one else could develop
that technology.

54

55
56
57
58
59
60

Kurt M. Saunders, Patent Nonuse and the Role of Public Interest as a Deterrent to
Technology Suppression, 15 Harv. J. Law & Tec. 389, 391-92.
Saunders, supra note 54, at 392-93.
Saunders, supra note 54, at 393.
Saunders, supra note 54, at 393.
Saunders, supra note 54, at 393-94.
Saunders, supra note 54, at 394.
Saunders, supra note 54, at 394.
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This history of patent law and its abuses reflect how patent law has shifted
away from progress and public benefit in more favour of patent holders and
encouraging monopolies. This shift away from the idea of limited monopolies in exchange for progress and public benefit has given rise to abuses
in the patent system. These abuses must be addressed in order to begin
the shift back to the Constitutional principle of progress. Also, addressing
these abuses will hinder other forms of abuses once we begin a shift back to
progress.

III. Patent A buses

and

Solutions

A. Patent Trolls
The first example of patent abuse that reveals a move away from the Patent
Clause of the U.S. Constitution is “patent trolling.” The purpose of the
Patent Clause is to encourage innovation, so if patent trolling is a “‘tax on
innovation” and a “detriment to progress” then an argument can be made
for reform to protect the Constitution’s goal of promoting progress in science and useful arts.”61 Patent trolls, or “patent assertion entities,” focus
on aggressive litigation. For example, they threaten “to sue thousands of
companies at once, without specific evidence of infringement against any
of them; creating shell companies that make it difficult for defendants to
know who is suing them; and asserting that their patents cover inventions
not imagined at the time they were granted.”62 Patent trolls are the very
anti-thesis of patent law’s original purpose because they hinder innovation.63

i. Defining Patent Trolls
First, there is the daunting task of defining a patent troll. One must practice
caution in defining patent trolls to avoid broad generalizations, which would
result in legitimate entities inclusion in the definition. Patent troll is a pejorative term, but the use of the term is still permitted in court.64 This article
61

62

63
64

Thomas H. Kramer, Proposed Legislative Solutions to the Non-Practicing Entity Patent
Assertion Problem: The Risks for Biotechnology and Pharmaceuticals, 39 Del. J. Corp.
L. 467, 473.
Grace Heinecke, Pay the Troll Toll: The Patent Model System is Fundamentally at Odds
with the Patent System’s Goals of Innovation and Competition, 84 Fordham L. Rev.
1153. (quoting Exec. Office of the President, Patent Assertion and U.S. Innovation (2013))
https://www.whitehouse.gov/sites/default/files/docs/patent_report.pdf.)
See generally, Heinecke, supra note 62.
Kramer, supra note 61, 472, FN 23 (citing James Beeson & Michael J. Meurer, The Direct
Costs from NPE Disputes, 99 Cornell L. Rev. 387, 420).
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will not explore what term of art should be precisely used for patent trolls,
but the term patent troll will be used throughout this article.
The White House uses the term “patent assertion entities” rather than the
term, patent trolls,65 but the terms are synonymous. The White House does
not give a bright line definition of patent trolls, but rather, lists out factors
that are typical behavior of patent trolls. Patent trolls should not have a
bright-line definition, but rather be determined by a set of factors as they are
in the White House Report.

a. The White House Factors
The White House outlines seven business characteristics of patent trolls.
These characteristics in combination with other exigent factors should be
used to determine if an entity is a patent troll.
“(1) They do not practice their patents; that is, they do not research
or develop any technology or products related to their patents; (2)
They do not help with ‘technology transfer’ (the process of translating
the patent language into a usable product or process); (3) They often
wait until after industry participants have made irreversible investments before asserting their claims; (4) They acquire patents solely for
the purpose of extracting payments from alleged infringers; (5) Their
strategies for litigation take advantage of their non-practicing status,
which makes them invulnerable to counter-claims of patent infringement; (6) They acquire patents whose claim boundaries are unclear,
and then (with little specific evidence of infringement) ask many companies at once for moderate license fees, assuming that some will settle instead of risking a costly and uncertain trial; (7) They may hide
their identity by creating numerous shell companies and requiring
those who settle to sign non-disclosure agreements, making it difficult
for defendants to form common defensive strategies (for example, by
sharing legal fees rather than settling individually).”66

These factors strike a balance between adequately defining patent troll
while avoiding overbroad drafting. For example, universities often licence
their patents to other entities, and do not actually utilize the patents they created themselves. However, it would be absurd to characterize all universities
who do this as patent trolls because this is a legitimate practice. This is why
in addressing the issues of patent trolls, it is vital to avoid broad, sweeping
65

66

“Patent Assertion and U.S. Innovation,” Exec. Off. Of the Pres., June 2013, https://www.
whitehouse.gov/sites/default/files/docs/patent_report.pdf.
“Patent Assertion and U.S. Innovation,” Supra, note 65.
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language. On the other hand, patent trolls must be adequately defined to
address the issues that they cause. The White House Factors should serve as
a guideline for defining patent trolls by Congress. Additionally, these factors
should serve as a guideline for the courts when determining if a suit is, in
fact, a frivolous suit brought by a patent troll. Furthermore, these factors can
also serve as guidelines for assessing if an entity or individual is a patent troll
for the purposes of levying damages against them.

b. Patent Troll Prevention Act (Arizona Statute)
One statute that addresses the issue patent trolls is the Patent Troll Prevention
Act, which was passed by the Arizona legislature. This statute outlines factors that the court may consider in determining if an entity has made a bad
faith patent infringement assertion or a good faith patent assertion. This
statute is similar in the approach suggested in this article. The court should
utilize factor tests in order to determine if an entity is in fact a patent troll
to prevent overbroad bright line rules, while addressing the issue of patent
trolls effectively.
One of the factors for considering an entity as a patent troll is (1) if the
demand letter does not contain all of the following: “(a) the patent number
issued by the USPTO or foreign agency, (b) name and address of the patent
owner or assignee, if any, (c) facts relating to the specific areas in which the
target’s product, service, or technology infringes the patent or is covered
by the claims of the patent, (d) an explanation of why the person making
the assertion has standing, if the assignment system of the USPTO does not
identify the person asserting the patent infringement as the owner.”67 The
statute outlines other factors as well. (2) If the patent troll’s “target requested
the information mentioned before, and the other party failed to give that
information in a reasonable time,” then the other party may be considered
a patent troll.68 Other factors include: (3) if the person making the demand
did not previously compare the complaints in the patent to the target’s own
product, (4) the demand requires a licensing payment “within an unreasonably short period of time, (5) the person knew or should have known
that the assertion was without merit, (6) the assertion of patent infringement contains false, misleading or deceptive information, (7) the person or
a subsidiary or an affiliate of the person has previously filed or threatened
to file one or more lawsuits based on the same or substantially equivalent
assertion of patent infringement and a court found the person’s assertion

67
68

2016 Ariz. HB 2386
Id.
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of patent infringement to be without merit.69 The statute also allows courts
to consider other factors, the court deems relevant, as well.70 This statute,
like the White House factors, clearly takes measures to identify patent trolls
without making an overbroad bright line rule. The Arizona statute should
serve as a guideline for Congress to adopt similar federal standards. This set
of factors prevents legitimate companies and inventors from being swept up
by an overly broad definition of patent trolls. This factor test should also be
used to empower the judiciary to determine what entities are patent trolls on
a case-by-case basis, rather than an overly broad statutory standard.

ii. Patent Trolls and Their Impact on Innovation
Now the question turns to if in fact patent trolls harm innovation.71 Direct
“out-of-pocket” expenses for defendant firms total $29 billion, “in aggregate, patent litigation destroys over $60 billion in firm wealth each year.”72
Research also shows that entities targeted by patent trolls reduced innovation compared to entities that were not targeted.73 Surveys found that entities significantly decreased in their ability to innovate due to patent trolls.74
Frequent patent trolls also caused a decline in venture capitalism investments.75 It is clear that patent trolling has, in fact, inhibited innovation, and
as the purpose of patent law is to promote innovation there must be change.
There is an argument that patent trolls actually add to the economy by
creating a secondary market. One feature of this secondary market is the
rise of corporations emerged which help people buy and sell patents.76 Patent
auctions are also increasing. Previously, this type of auction would only happen with bankrupt sellers auctioning off patents. Recently, a wide variety of
patent sellers and purchasers buy and sell patents in this way.77 Thereby, it
is argued, that this creates more innovation because this gives inventors the
ability to make a profit by selling their patents. As a result, inventors will
be encouraged to invent from this incentive because of the inventor’s ability
to make a profit from the invention quickly. However, these auctions also
present an opportunity for patent trolls to purchase patents, which will then
69
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inhibit innovation. There is a way in which patentees can sell and other entities can purchase patents while encouraging innovation. The key to solving
that issue is by ensuring that those patents are actually utilized. This article
will explain how to solve the issue of patent trolls obtaining these patents,
yet doing nothing with them, can be solved through compulsory licensing in
the patent shelving section.
It is also proposed that patent trolls actually encourage inventors to use
their patents, since they usually target patents that are not in use; however,
this argument is weak. It is clear that there are other ways to encourage
inventors to utilize or license their patents legitimately without the looming
threat of patent trolls. Additionally, the negative impact that patent trolls
have on innovation and development heavily outweighs the mere possibilities that they create a secondary market or encourage innovation in a circular way.

iii. Solutions to the Patent Troll Problem
The Constitution permits Congress to change patent law to promote innovation, so a legislative response to patent trolling is warranted. One of the
reasons that patent trolling is so prevalent is because people keep “feeding
the trolls,” in other words, legitimate entities are more likely to pay a patent
troll’s demands, rather than go through expensive litigation. The first way
this could be solved is through the patent process itself. More resources must
be given to the USPTO in order to prevent patent trolls from obtaining patents in the first place. In addition, since the Patent Clause gives Congress the
power to enforce laws in order to encourage progress in the useful arts and
sciences, then Congress should use the White House Factors as a guide for
defining patent trolls, then pass a law that is similar to the Arizona statute,
in which federal courts will then have guidelines by which to determine
whether or not an entity or individual is a patent troll.
The determination of an entity being a patent troll or not should be a
question of law and not fact. One reason that entities settle with patent
trolls is because patent verdicts are unpredictable, which makes litigating
against patent trolls risky.78 This causes many entities to believe it is safer
and easier to simply “pay the troll.” A legal standard used to determine if an
entity is a patent troll would be more consistent and precedent could build
which would make this litigation much more predictable. More predictable
78
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outcomes would decrease the risk in litigating patent trolls. Patent trolls
would no longer be able to take advantage of this unpredictability to force
entities into paying them.
The punishments for patent trolls should also be more severe. Entities are
hesitant to fight patent trolls because the cost of litigation often outweighs
the benefits.79 Judges should be encouraged to award punitive damages more
often in cases of egregious and clear patent trolling. The use of possible
punitive damages will also encourage targets of patent trolls to countersue
rather than pay the patent trolls’ demands, since there is a financial incentive. This would reduce the amount of settlements, upon which patent trolls
rely, and in turn, reduce patent trolling.
In addition, judges should also be encouraged to award attorney’s fees
to help offset the cost of fighting a patent troll. Currently the awarding of
attorney’s fees in a patent infringement suit is governed by 35 U.S.C. § 285
which provides that attorney’s fees are awarded if the case is exceptional.80
It is understandable that judges are hesitant to find a case exceptional, since
there are little other guidelines. Under the Patent Abuse Reduction Act, this
statute is slightly amended to shift the costs to an affiliated party of the
non-prevailing party, which would be a way to get into the pockets of the
shell company that often is the entity truly behind the patent troll.81 This
statute has not led to increased cost shifting because there is little outlining
in how the procedure for shifting costs should be done.82 The proper way
to solve this is instead of simply stating that judges can shift the costs, is to
outline when that may be appropriate. The proper solution to this would
once again be the factor tests that are outlined in the Arizona statute and the
White House’s defining factors of a patent troll. By using those tests it will be
clear when an entity is indeed a patent troll and if those factors are convincing, then damages for attorney’s fees should be imposed and encouraged.
Using these factors in future cases will also allow courts to build precedent
for when to award theses damages.

B. Overbroad Patents
Overbroad patents are another issue that must be reformed to return to the
constitutional principle of innovation. Software patents are often overbroad
because the patent will give the inventor patent rights that “go beyond the
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technology that an inventor has actually invented and disclosed.”83 Then
the inventor will threaten litigation against other inventors whose inventions may happen to fall under such broad construction claims. In this way,
inventors use patent law as a sword to cut down competitors and innovation, instead of as a shield to protect their legitimate interests, as patent law
intended.
Overbroad patents are often taken advantage of by patent trolls as well,
who are then able to assert patent infringement against their targets for a
patent that goes beyond what was even created.84 Preventing overbroad patents would also help solve the previously mentioned patent trolling issue.
Congress has not taken many effective recent measures in combatting overbroad patens. However, the judiciary has addressed overbroadness in claim
construction. The courts should develop more concise and clear rulings on
claim construction and answer questions regarding this issue that were previously left unanswered.

i. Claim Construction and a Solution? Claim Construction and a
Solution?: Why the Court Should Have Granted Cert to Hear
Google Inc. v. Cioffi and Should Solve Overbroad Patents in the
Future
Overbroad patents are granted because the USPTO is “overworked, understaffed, and underfunded.”85 Overbroad patents are often granted because
of the claim construction process. In this process, patent attorneys write
claims for a patent as broadly as possible, in order to expand a patent holder’s rights and monopoly as broadly as possible.
Google asserted a petition for cert in Google Inc. v. Cioffi. In the petition,
Google claimed that the current claim construction process “leads patent
lawyers to play games with the Patent Office, and in the event of a lawsuit,
to allow patent owners to benefit from ambiguous phrasing they’re responsible for in the first place.”86 This petition arose out of Cioffi v. Google Inc.
over Cioffi’s patent for anti-malware software. Cioffi claimed that Google
Chrome infringes on its “web browser process.”87 The district court ruled in
favor of Google, but the appeals court held that Chrome’s method of finding
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malware infringed Cioffi’s patent.88 Earlier the Patent Office rejected Cioffi’s
claim because the Office stated that the process they described, which was a
secondary computer process outside the browser itself, was already invented.
So, Cioffi tweaked the language.89 However, there is no clear definition for
“web browser process.” The Appeals Court held that there was no “clear
and unmistakable statement” which supported Google’s case, so the court
reversed in favor of Cioffi.90 Google argued in its petition that the “clear and
unmistakable standard” is too high, and this uncertainty in software patents
benefits patent trolls.91 “Overbroad patent claims are a plague, especially in
the vital and growing high-tech sector. All of this plays into the hands of
entities that buy patents and then use litigation or the threat of litigation to
extract settlements from alleged infringers.”92
Google’s petition asked the Supreme Court to address the questions once
and for all: should courts examine prosecution history to determine an
ambiguous term’s meaning, and when a patented claim is amended should
that amended language then be strictly construed against the applicant, or
should the court continue to use the “clearly and unambiguously disavows”
standard?93 The Court denied cert to Google,94 but the Court should have
granted cert to examine prosecution history in context to determine ambiguous terms. Technology advances quickly, and in that timeframe, the Court
should not reward those innovators who are best able to play with language
and semantics, rather the Court should enforce a “say what you mean and
mean what you say” standard. The Supreme Court should decide to hear
cases involving claim construction in the future, in order to prevent overbroad claim construction.

ii. A Silver Lining for a Claim Construction Solution: Columbia
University v. Symantec Corpn.
It appears that The Federal Circuit adopted the standard that Google
proposed in its petition, in the case, Columbia University v. Symantec
Corpn. In this case, the term in the claim at issue is “byte sequence feature.”95 Columbia’s claim construction, which was the subject of litigation,
88
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referred to language Columbia used in two previous different patents, but
that language seems to contradict one another. The court cited to Phillips
in which the court held that the “specification made is always highly relevant.”96 The court also stated in this case that the patentee cannot rely on its
own confusing language in order to support a patent. The court states, “the
claims are nonsensical in the way a claim to extracting orange juice from
apples would be, and thus are indefinite.”97 Therefore, Columbia’s patent
claims are invalid. The Court sent a clear statement that patentees crafting
language ambiguously and overly broad should not be permitted. The Court
especially frowned upon patentees who then relied on the ambiguous and
overly broad claim constructions to claim a patent beyond what the inventor
actually invented. Other courts should follow the logic of the Federal Circuit
in order to assert that an entity cannot rely on its own confusing language
to broaden a patent, in other words, “mean what you say and say what you
mean.” Rulings of this kind would ensure that patent trolls and overbroad
patent abuses are limited. Confusing litigation over confusing terms would
also decrease because patentees could no longer play semantic games with
the courts.
Additionally, Microsoft has called for the Court to abolish the “plain
and ordinary” meaning standard.98 “Plain and ordinary” meaning has been
interpreted by courts to mean something outside the context of the patent.99
Claim construction should be interpreted in the full context of the patent,
and the Court should clarify this point, rather than an overly broad, “plain
and ordinary” meaning standard.100 This means that, like Google’s claims,
patent holders will be held to the language they use in their patent, and
the context of the patent will determine the patent’s claims, rather than an
ambiguous “plain meaning standard.”
The Court should have granted cert to Google Inc. v. Cioffi, but when
another opportunity to hear a similar case arises, the Court should rule on
it. For now, courts should adopt the standard of Columbia University v.
Symantec Corpn., to curb overbroad claims by abolishing the “plain and
ordinary” meaning standard. In the future, the Court should adopt a “say
what you mean and mean what you say” standard, in which the Court interprets claim construction strictly and in the context of the patent.
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iii. Kill Two Birds with One Stone: Answering the Questions in Bilski
The Court should also comment on, if not hold, a more specific ruling for
software patents in future cases. There is a proposition that patent law
requires a “software-specific patch.”101 A solution is to “root a protectable
invention in the algorithms that an inventor actually employs to achieve a
claimed function, and they can limit the scope of functional software claims
to particular algorithms for achieving the claimed functions.” This approach
is the best way to solve the issue of overbroad patents.
The very nature of software, in that it is functional and expands rapidly,
means that patents in this area must be scrutinized for overbroadness. As
software technology advances and develops exponentially, a patent for 20
years is a very serious and could create a powerful monopoly. This article
will not address whether software patents in themselves should be limited less than 20 years. With that consideration, if an overbroad patent is
granted, it will mean that no development of what is claimed can be done for
20 years other than that of the patent holder; therefore, to keep innovation
moving forward software needs its own patch, and overbroad patents must
be reined in.
In Bilski v. Kappos, the Supreme Court held that a “machine-or-transformation” test, is not the sole test to determine the patentability of a business
practice algorithm, but the Court failed to discuss the standards under which
other algorithms or software patents should be held to.102 The “machine
or transformation” test requires a restriction to one machine or device or
“transform[ation] from one form to another.”103 The Court in Bilski held
that the machine-or-transformation test was a “useful and important clue,
an investigative tool, for determining whether some claimed inventions are
[patentable processes]. The machine-or-transformation test is not the sole
test for determining whether an invention is a patentable “process.”104 The
Court left open many questions with this case, and these questions must be
resolved to prevent overbroad patents and improve innovation. This standard should be clearer regarding algorithms and software. The way in which
to do this would be to provide the “patch” for software patents in patent
law. Software patents should be treated differently than other patents. The
standard should be the specific tasks, unique to that particular software,
that is claimed are patented, and nothing more. The claim construction in
101
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software patents should also be interpreted more narrowly, since software
develops from previous software. This would be a proper judicial solution to
the issues that Congress has failed to address. Congress also has the power
to abolish software patents entirely, but that issue is beyond the scope of this
article.
The judiciary solution would help streamline the software patent process,
reduce confusing terms, reduce litigation, reduce patent trolling, and reduce
overbroad patents. In this way, the courts will be able to solve software patent issues more efficiently under this new system, since the law on software
would be more clear. Also, this will increase other developers’ ability to
innovate without fearing lawsuits due to infringing on an overbroad patent.
Additionally, the USPTO should have its own division that deals specifically with software patents. The USPTO should be divided per industry,
in order to organize and improve the patent process overall. This will obviously require more investment in the USPTO, but innovation would then go
forward.
Limiting the use of overbroad patents would also help to limit patent
trolls. Patent trolls often buy overbroad patents in order to sue as many entities as possible. By not granting these overbroad patents in the first place,
then the issue of patent trolling is also partially resolved. Additionally, limiting overbroad patents will help to solve the next patent abuse discussed,
evergreening.

C. Evergreening
Evergreening is another issue that must be solved by returning to the Patent
Clause. Evergreening occurs when a patent holder modifies a patent while
under patent protection, so they can then apply for an extension of the patent, thereby extending the monopoly granted to the patent holder by the
initial patent.105 Often these modifications are arbitrary106, so the patent
holder is able to extend their monopoly, while not making any truly innovative modifications to the patent. Extending that monopoly is harmful to
innovation.
Evergreening is especially problematic and prevalent in the pharmaceutical industry, so this article will mainly focus on evergreening in that context.
Evergreening, in the context of the pharmaceutical industry, “occurs when a
105
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drug manufacturer makes small improvements to an old medicine, allowing
it to renew its patent and to extend the time it will enjoy monopoly control
rights.”107
A few examples of small modifications for drugs to obtain evergreen status include changing the milligram strength of medication, changing the
medication’s form (such as from a pill to a capsule), changing the delivery method (such as from injection to inhalation), expanding the medicine’s
application to more conditions, using time-release mechanisms, and adding
sugar molecules to the formula.108 These small modifications are not innovative, so these changes should not lead to an extension of a patent. The whole
purpose of patent law is to give an inventor a monopoly over the patent for
a limited time in exchange for eventually allowing the public to use that
patent. Innovation occurs when people develop off of their predecessor’s
ideas.109 If that monopoly is simply perpetuated over and over, then it will
be impossible for innovation to occur, which is antithetical to the Patent
Clause. The Constitution calls for Congress to act to encourage innovation,
so this issue calls for a legislative solution.
In 2003, Congress enacted legislation to curb evergreening by allowing no more than one 30-month stay per product.110 In addition, Congress
passed the Patent Reform Act of 2007, which only allows a patent holder to
file two continuation or continuation-in-part applications and one request
for continued examination.111 However, continuations still make up a large
percentage of the patent applications received by the USPTO. The USPTO
estimates that about one third of the patent applications they receive are continuation patents.112 It is also estimated that without continuation patents,
the USPTO would be able to operate more efficiently.113 Therefore, further
actions should be taken in order to decrease continuations, so the USPTO
will operate more efficiently. A more efficient USPTO will progress the useful arts and science by ensuring that patents are granted in a timely and
proper manner. It is evident that the Patent Reform Act of 2007 has not been
effective in curbing continuation patents. Further actions must be taken by
Congress to prevent evergreening.
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i. It’s Not Easy Being Green: India’s Section 3(d)
India addressed the issue of evergreening through section 3(d). India’s section 3(d) law does not allow the granting of patents if the claim is a “mere
discovery of a new form of a known substance which does not result in
the enhancement of the known efficacy.”114 India’s Supreme Court held that
“under the scheme of a patent, a monopoly is granted to a private individual
in exchange of the invention being made public so that, under the end of
the patent term, the invention may belong to the people at large who may
be benefited by it.”115 The Supreme Court of India further stated that “[p]
rotecting inventions that are already generally known to a skilled person
does not induce inventors to undertake commercially relevant research.”116
India’s principle of patent law is the same as it is in the United States. A
monopoly is given in exchange for the limited nature of the monopoly, so
innovation will be encouraged, and then others can develop on that innovation, thus progress in the useful arts and sciences will be made. Therefore,
a statute such as the one in India would provide a valid framework for preventing evergreening. And that statute, with modifications, would be constitutional, since the principles of our patent laws: innovation and progress
are nearly identical.
Monopolies negatively impact consumers; however, a balance must also
be struck to encourage innovation.117 The Constitution does allow a limited
monopoly to inventors in exchange for the innovation their invention fosters.
Balance is key in solving this issue. Groups such as Doctors Without Borders
are concerned that a lower for patentability would cause a market for generics to disappear.118 This would perpetuate a pharmaceutical company’s
monopoly and drug costs for consumers would remain high. Furthermore,
a patent would prevent other pharmaceutical companies from creating new
medications for a longer period of time. Conversely, there is a valid concern
that drug manufacturers will choose not to sell drugs in nations with higher
patentability standards, thus, the drug costs will also remain high in that
scenario.119 Therefore, a careful balance must be struck. A limited monopoly
must be granted to encourage pharmaceutical companies to develop, market, and sell their products in the United States. A limit to continuation patents and patents that are truly not innovative based on prior art should also
114
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be imposed. This would ensure that the monopolies granted stayed limited,
a competitive market flourishes, and others are able to innovate based on
the patented medication within a reasonable time. I advocate that a measure
similar to § 3(d) would benefit the United States, although with modification
to strike a balance between creating incentives to invent through granting
limited monopolies and fostering innovation.

ii. How the United States Can Use Section 3(d) as a Framework for a
Statute to Prevent Evergreening
The United States should enforce a measure such as § 3(d), but enforcement
of the statute should only occur after the pharmaceutical company begins to
enjoy the initial patent. An efficacy standard from this statute would not bar
all continuations in entirety. Rather, issuing continuances on patents would
be rarely granted, and the standard for issuing continuances would be strict.
There should be a “clear and convincing” standard that the product is truly
innovative for approving any continuance, and those continuances should
not extend nearly as long as a patent itself. This would prevent pharmaceutical companies from filing frivolous claims, but the claims would not be
barred completely. In this way, the pharmaceutical company would not be
able to perpetuate a monopoly; however, they would still be encouraged to
innovate and continue research on medications.
The “improvement” justifying a continuation must be scrutinized, particularly under the no obviousness standard. A drug earning a continuation
based on being offered in a capsule rather than a tablet, or even by a milligram change are obvious changes, so continuations should not be granted
in those scenarios. If a continuation is granted, then it should just be based on
the specific improvement. In other words, people should be allowed to freely
develop on the original patent, so long as they do not infringe on the original
patent holder’s improvement. In particular, pharmaceutical continuations
should still be permitted rather than barred. This is because pharmaceuticals are highly complex, the product takes a long time to develop, and time
and expenses for experimentation are high.120 The regulatory review that a
new drug must undergo can take up to 14 years. This time period effectively
“eats up” much of the patent time period, which is 20 years.121
Pharmaceutical companies argue that limiting continuations would
actually impede on innovation.122 This is because without proper patent
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protection, they claim that there would be no incentive to develop drugs
because the research costs would outweigh the profits earned by a limited
monopoly.123 However, if FDA reform happened to where the process of regulatory review were streamlined to shorten the review period for new drugs,
then the monopoly enjoyed by the pharmaceutical company would not be
“eaten up” as much. This article will not explore ways to reform the FDA,
but it is a viable option to balance both safety and efficiency performed by
regulatory review in the future. Additionally, there would still be benefits
to developing new and innovative drugs, not all of them financial. Also,
the purpose of the Patent Clause is to create innovation, not to perpetuate
monopolies and protect industries, so the industry’s incentives are not the
patent clause’s priority, but balance must be struck for public policy reasons.
The backup in the Patent Office caused by continuation patents are hindering innovation. It is evident that the Patent Reform Act of 2007 has not
effectively hindered pharmaceutical companies from filing continuations,
nor has it helped entirely in streamlining the process of patent approval.
Also, the remedy proposed in this article does not hinder continuations completely, the standard is simply raised in order to return from the unconstitutional practice of granting perpetual monopolies and return to the
constitutional practice of granting limited monopolies to benefit society.
This solution will help return the principles of the Patent Clause, but it will
also benefit consumers. Limiting evergreening will ensure that pharmaceutical companies cannot maintain a perpetual monopoly, so competition will
be able to enter the marketplace. This competition will cause prices to drop
and consumers will be able to afford the medication they need.
Limiting evergreening will also help to curb overbroad patents.
Evergreening allows an entity to maintain a monopoly, so that patent holder
can keep other competitors out of their particular market for longer. By
curbing evergreening, the monopoly will not be as broad, which will encourage innovation, rather than limit it.

D. Patent Shelving
Another form of patent abuse this article will discuss is “patent shelving.”
Patent shelving occurs when a company obtains or creates “a patent to prevent its development and marketing.”124 All a company must do is buy the
patent,125 or choose to not utilize a patent of its own creation. Patent shelving
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ensures that the patent holding entity maintains a patent, but never utilizes
it; rather, the patent is used to prevent other potential competitors from
innovating or utilizing similar inventions. Patent shelving can increase profits due to control of the market, but this can lead to deadly consequences
in industries such as the pharmaceutical companies because companies are
intentionally not marketing potentially life-saving technology.126 Patent
shelving also can occur to ensure an industry holds its power or prevent
radical changes in that industry.127 This action is an obvious hindrance to
innovation. The very concept of patent shelving should not be seen as an
innovative business practice, but rather a violation of the spirit of patent law.
Science and the useful arts cannot progress if inventions are obtained solely
to preserve a monopoly or stronghold in a market.
Sometimes patents simply have no value, so those patents’ lack of utilization is not the concern. Those patents do raise a question of if those patents
should have been granted based on utility in the first place though. However,
there are other valid reasons to not utilize a patent, such as profitability and
marketing. Solutions to patent shelving should be made mindfully of those
valid concerns, while still preventing entities from manipulating and controlling the market.
The Supreme Court held that patentees are not required to “use or commercialize their patents.”128 However, the public would benefit greatly if
patentees were at least required to make a good faith effort to utilize, commercialize, or license the patent in order for the public to benefit. Patent
shelving is clearly opposed to the principle of the Patent Clause because patent shelving is used simply to bar competitors from competing in the marketplace. Protections against this behavior should be enforced, since patent
shelving is not conducive to innovation, but rather hinders it.
Additionally, many researchers obtain government funding and grants
to perform research and eventually develop patents. There is especially an
interest in utilizing those patents for public use, rather than allowing government funds to help someone maintain a monopoly or get rid of competition
with zero benefit to the public.129
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i. The Precedent for Shelving Patent Shelving and How We Got Away
from the Constitution
It appears as if precedent shows that there is an absolute right to not utilize
a patent.130 Yet there is judicial precedent for patent holders to make a good
faith effort to utilize their patents in some way. In fact, federal courts initially “attempted to precondition an infringement remedy on the patentee’s
use of the patent.”131 In Hoe v. Knap, the court declined to enjoin a patent
infringer of a printing press patent. The court held, “…under a patent which
gives the patentee a monopoly, he is bound to either use the patent himself
or allow others to use it on reasonable or equitable terms.”132 In another
case, the court held that “[a] patent for invention which the patentee refuses
to make available himself, and refuses to allow others to make useful, is
not within the spirit of the provision of the constitution which assigns as
a reason for securing exclusive rights to authors and inventors to desire ‘to
promote the progress of science and useful arts…’”133 It is clear that the
courts in these cases clearly understood that patents were to be granted in
exchange for progress. However, later rulings reflected a shift in the law. In
Continental Paper Bag, the Court held that not using a patent, yet refusing
to license a patent was fully within the rights of a patentee.134 This marks a
dramatic shift away from the spirit of the Patent Clause. The Patent Clause
does not ensure that inventors have an exclusive right solely because they
invented a thing; rather the right of a patent is granted for the progress of
the useful arts and sciences. It is evident that the purpose of patent law has
been lost in recent times, it must be corrected.

ii. Compulsory Licensing
Many World Trade Organization members have compulsory licensing laws
to prevent this patent abuse.135 Compulsory licensing occurs “when a government allows someone else to produce the patented product or process
without the consent of the patent owner.”136 Article 5 of the Paris Convention
states that a compulsory license cannot be issued for less than four years
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after the patent application is filed or three years after the patent is issued.137
In addition, the compulsory licence is not mandated if the patentee has a
legitimate excuse such as legal, economic, or technical reasons why the patentee has chosen not to utilize the patent.138 The United States attempted
to enact this in the Hart Bill in 1973, which would implement compulsory
licensing for “patents related to public health, safety, energy, or protection
of the environment.”139 This bill also would not have compulsory licensing
unless three years after the patent was issued or four years after filing.140
However, powerful lobbying defeated this bill.141
A form of the Hart Bill should be passed and patents related to technology should be added to the list as well, since technology is such a quickly
developing and increasingly vital sector of modern society. In this legislation, compulsory licensing should be very limited in order to strike a balance
between the patentee’s rights and the public benefit. The patentee should be
allowed to give legitimate economic, legal, or technical excuses for not being
required to attempt to licence. In addition, industries that are more complicated such as pharmaceuticals should be given a time period longer than 3
or 4 years. Instead, pharmaceutical industries should be given 5 to 7 years to
make a good faith effort to develop or commercialize their patent.
This supposed “absolute right” to not use a patent clashes with the principles of the Patent Clauses. The purpose of a patent is to encourage innovation, not to hinder others from innovating, so compulsory licenses would be
in line with the Constitution. The precedent that there is an absolute right
to not use a patent should be overturned by the Court, and legislation for
compulsory licences should be enacted, so as to return to the principle of
innovation in the Patent Clause.
There is also an argument that large corporations may be able to litigate
compulsory licences for a lengthy period of time and competitors may decide
to not take advantage of the compulsory licence in an attempt to control
and manipulate the market.142 However, a situation where no corporation
licenses the product purely for anti-competitive purposes, could be solved
by anti-trust provisions. But, it may be difficult to prove that corporations
137
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are purposely refusing to market a patent made available by a compulsory
license so they can control the market; however, it is unlikely that all competitors would conspire together to shelve a product if it was truly innovative
and beneficial. The incentive for potential profits without having to pay for
the initial development would likely outweigh a corporation’s interest in participating in those anti-competitive measures.
Ceasing patent shelving will also help to prevent patents from being
unused. Often, patent trolls will buy up unused patents. By ensuring that
unused patents are very limited through compulsory licensing, then patent trolls will be unable to purchase unused patents for litigious purposes.
Thereby, preventing patent shelving will also prevent patent trolling, while
also encouraging innovation and progress.

IV. Conclusion
Patent trolling, overbroad patents, evergreening, and patent shelving are
all patent abuses that reveal one problem: Patent law has abandoned the
principle of the Patent Clause in the U.S. Constitution. The principle underlying the Patent Clause is simple: progress. An inventor is given a limited
monopoly as an encouragement for inventors to invent. These inventions
will benefit society, and eventually society is given the rights to that patent,
so others may innovate that patent. Patent trolling seems as if it is a minor
nuisance, but it is more than that. Patent trolls hinder corporations and individuals from innovating. Rather than broad legislation that may punish genuine businesses and entities, a factor test should be passed by Congress as a
way for the judiciary to determine if an entity is a patent troll. Furthermore,
the standard for awarding damages such as attorney’s fees must be lowered
by using that same factor test to determine the egregiousness of the conduct.
In this way, the courts can build a precedent for dealing with and punishing
patent trolls.
Overbroadness in patents is another abuse, especially prevalent in high
technology. The Court should have granted cert to Google in order to solve
this issue by requiring narrower claim construction in a “say what you mean
and mean what you say” standard. Columbia University follows that logic,
so courts should follow this reasoning. In addition, the Court should use
future software patent cases as an opportunity to address the questions left
open by Bilski. There needs to be a specific software “patch” in patent law,
in which software patents are granted patents more appropriate in the context of the technology industry.
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Evergreening in an age of increasing drug costs must also be prevented.
Evergreening can be prevented by using India’s Section 3(d) law as a framework for a United States statute. This statute should be modified in order
to not ban continuations completely, so pharmaceutical companies will still
research and develop their drugs, but also stop the abuse of the continuation
patent in order to preserve monopolies, rather than create progress.
Patent shelving can be prevented by compulsory licensing and the Court
returning to the law that a monopoly is granted, but only in exchange for
progress and innovation. Compulsory licensing simply requires that a patentee make a good faith effort to utilize their patent, so the public may
benefit within a certain time period within certain patents involving health,
technology, and environmental industries. When a compulsory licence is
granted other corporations can then utilize that patent which will improve
innovation while also improving lives. Legitimate economic, legal, and technical excuses would still be allowed as to not require compulsory licensing.
However, entities should not be allowed to deprive the public of a patent’s
use to perpetuate a monopoly, when the whole reason that monopoly is
granted is in the name of progress.
Discussing these patent abuses together does not just reveal a shift in
patent law away from the patent law, but discussing these patent abuses
together and solving these abuses individually will assist in curbing other
forms of patent abuses as well. Limiting patent shelving and overbroad patents will help curb patent trolling, and limiting evergreening will help curb
overbroad patents. So, it is important that patent abuses are discussed in
conjunction with one another. Only when we address various types of patent
abuses as a whole and examine how they are connected, can one truly realize the issues with patent law and how to best solve these issues.
All of these patent abuses point to a swing in the pendulum from progress
to using patent law to protect corporate interests. Balance must be restored.
There is Constitutional basis under the Patent Clause for these issues to be
addressed and resolved. The United States must return to the principle of
progress as mandated in the Patent Clause in order to balance the economic
interests of inventors and progress.

